Oh, but we used mathematical models to pick the dose, they said.
The Solidarity Trial is a WHO-led conglomeration of many national trials of treatments for Covid-19. In March 2020 alone, the WHO collected $108 million from donors to cover the costs of its Solidarity clinical trials. After the overdosing was exposed, WHO claimed it paid for the trial itself, perhaps to cover for a donor?
Per the WHO:
As of 3 June 2020, more than 3500 patients have been recruited in 35 countries, with over 400 hospitals actively recruiting patients. Overall, over 100 countries have joined or expressed an interest in joining the trial, and WHO is actively supporting 60 of them…
The hydroxychloroquine arm of the Solidarity trials restarted enrolling patients June 3, after being halted May 25 by WHO Director-General Dr. Tedros Adhanom Ghebreyesus and the Executive Group of the Solidarity Trial. The hydroxychloroquine (HCQ) arm of the trials had been stopped after publication of the Lancet Surgisphere study, which claimed that patients who received chloroquine or hydroxychloroquine had 35% higher death rates, but the Lancet study was retracted 13 days after publication, as its data turned out to be fabricated. The HCQ Solidarity trials restarted after the retraction and were currently ongoing in June 2020. [However, the international outpatient HCQ trial sponsored by Oxford (COP COV) was not allowed to resume then.]